A Multicenter, Double-Blind, Controlled Study to Evaluate Ampligen
NCT00002269 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL
Last updated 2005-06-24
Summary
To evaluate ampligen at two dosage levels given twice weekly in combination with zidovudine (AZT) versus AZT alone in individuals with HIV-related immune dysfunction defined as T4 count between 100 and 300 cells/mm3.
Conditions
- HIV Infections
Interventions
- DRUG
- DRUG
-
Zidovudine
Sponsors & Collaborators
-
HEM Research
lead INDUSTRY
Study Design
- Purpose
- TREATMENT
- Masking
- DOUBLE
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
A Multi-Center, Placebo-Controlled, Double-Blind, Randomized Trial Comparing the Virologic and Immunologic Activities of 400 Mg Nevirapine in Combination With Zidovudine Versus Zidovudine Alone in Asymptomatic HIV-1 Infected Patients With 4-12 Months of Prior Zidovudine Therapy and 200-500 CD4+ Cell
NCT00002323 ·Status: COMPLETED ·Phase: NA
-
Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV
NCT00001119 ·Status: COMPLETED ·Phase: NA
-
An Open-Label, Staggered Rising Dose Cohort Study Assessing the Pharmacokinetics, Safety, and Tolerance of BI-RG-587 in Combination With Zidovudine in Patients With HIV Infection (CD4+ Cell Count < 400/mm3)
NCT00000649 ·Status: COMPLETED ·Phase: PHASE1
-
A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients
NCT00002168 ·Status: COMPLETED ·Phase: NA
-
The Incidence and Severity of Drug Interactions Before and After Switching Antiretroviral Therapy to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment Experienced Patients
NCT03789968 ·Status: COMPLETED
-
A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients
NCT00002307 ·Status: COMPLETED ·Phase: NA
-
The Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Never Used Anti-HIV Drugs
NCT00001067 ·Status: COMPLETED ·Phase: PHASE2
-
The Effectiveness of Indinavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients With No Symptoms of Infection
NCT00002179 ·Status: COMPLETED ·Phase: PHASE4
-
Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure
NCT00038506 ·Status: COMPLETED ·Phase: PHASE4
-
The Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined With Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs
NCT00002379 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
NCT00002369 ·Status: COMPLETED ·Phase: NA
-
A Phase I Study to Evaluate the Pharmacokinetics, Safety and Antiviral Effects of Concurrent Administration of Zidovudine (AZT) and 2'3'-Dideoxyinosine (ddI) in Patients With Human Immunodeficiency Virus (HIV)
NCT00002014 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Steady State TPV/r on Intracellular Concentrations of Zidovudine and Carbovir for Patients With HIV
NCT02229760 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
The Safety and Effectiveness of Zidovudine Plus Acyclovir in Patients With Early HIV Infection
NCT00002290 ·Status: COMPLETED ·Phase: NA
-
A Study on the Safety and Effectiveness of Adefovir Dipivoxil in Combination With Anti-HIV Therapy (HAART) in HIV-Positive Patients
NCT00002426 ·Status: COMPLETED ·Phase: NA
-
A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)
NCT00000781 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Compare the Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients
NCT00002448 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV Drugs
NCT00004852 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of a Combination of Four Drugs in Patients With Recent HIV Infection
NCT00002233 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients
NCT00000896 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (MK0518-018 EXT2)
NCT00293267 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate, 800 Mg q 8 h Versus 1,200 Mg q 12 h in Combination With Zidovudine and 3TC
NCT00002208 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase II Open-Label Exploratory Study of Saquinavir + Zidovudine + Lamivudine in HIV Infected Patients
NCT00002190 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (0518-019)
NCT00293254 ·Status: COMPLETED ·Phase: PHASE3
-
Zidovudine / Lamivudine + Nevirapine Twice Daily, Versus Tenofovir + Lamivudine + Nevirapine Once Daily in ARV-Naive Patients
NCT00199979 ·Status: UNKNOWN ·Phase: PHASE3